These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 37830597)
1. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus. Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V Cells; 2023 Sep; 12(19):. PubMed ID: 37830597 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate. Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF mBio; 2018 Sep; 9(5):. PubMed ID: 30228241 [TBL] [Abstract][Full Text] [Related]
3. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells. Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299 [TBL] [Abstract][Full Text] [Related]
4. Oncolytic Zika Virus: New Option for Glioblastoma Treatment. Zhou C; Chen Q; Chen Y; Qin CF DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682 [TBL] [Abstract][Full Text] [Related]
5. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy. Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903 [TBL] [Abstract][Full Text] [Related]
11. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches. Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100 [TBL] [Abstract][Full Text] [Related]
12. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors. Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031 [TBL] [Abstract][Full Text] [Related]
13. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells. Kanai R; Wakimoto H; Martuza RL; Rabkin SD Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062 [TBL] [Abstract][Full Text] [Related]